Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apotel with or without dexamethasone for prevention of postoperative nausea and vomiting after cesarean section
IRCT20201028049175N6Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Apotel + placebo with Apotel + dexamethasone (2 arms). Primary endpoints: Vomiting score and Occurrence of nausea. Started Feb 2021; status: completed.
02
Drugs
acetaminophendexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20201028049175N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201028049175N6.